Janux Therapeutics pops 100% on open after strong IPO (NASDAQ:JANX)

Biopharma firm Janux Therapeutics (Nasdaq: JANX) popped 100% on opening Friday in its first trading session following an upsized IPO priced at a top-of-range $17 a share.
Read More